Literature DB >> 26270133

How to develop novel treatments for EGFR-mutant lung cancer.

Giuseppe Luigi Banna1, Marcello Tiseo2.   

Abstract

Entities:  

Keywords:  EGF receptor; circulating tumor-derived DNA; liquid biopsy; non-small-cell lung cancer; repeated biopsy; tumor heterogeneity; tyrosine kinase inhibitors

Mesh：

Substances：

Year:  2015        PMID： 26270133     DOI： 10.2217/FON.15.172

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  3 in total

1.  PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?

Authors:  Alfredo Addeo; Giuseppe Luigi Banna
Journal:  Transl Lung Cancer Res       Date:  2018-09

2.  PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?

Authors:  Alfredo Addeo; Giuseppe Luigi Banna
Journal:  Transl Lung Cancer Res       Date:  2018-09

3.  The Promise of Digital Biopsy for the Prediction of Tumor Molecular Features and Clinical Outcomes Associated With Immunotherapy.

Authors:  Giuseppe Luigi Banna; Timothée Olivier; Francesco Rundo; Umberto Malapelle; Filippo Fraggetta; Massimo Libra; Alfredo Addeo
Journal:  Front Med (Lausanne)       Date:  2019-07-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.